Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11959080 Methods and compositions for inhibiting PMP22 expression

Patent 11959080 was granted and assigned to Ionis Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Ionis Pharmaceuticals

0

Current Assignee

Ionis Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Gene Hung0

Holly Kordasiewicz0

Eric E. Swayze0

Hien Thuy Zhao0

Date of Patent

April 16, 2024

0

Patent Application Number

174931120

Date Filed

October 4, 2021

0

Patent Citations

US Patent 7427672 Artificial nucleic acids of n-o bond crosslinkage type

0

US Patent 7034133 Oligonucleotide analogues

0

US Patent 7053207 L-ribo-LNA analogues

0

US Patent 7399845 6-modified bicyclic nucleic acid analogs

0

US Patent 8530640 Bicyclic cyclohexitol nucleic acid analogs

0

US Patent 8546556 Carbocyclic alpha-L-bicyclic nucleic acid analogs

0

US Patent RE44779 Bicyclonucleoside and oligonucleotide analogues

0

US Patent 8796437 Tetrahydropyran nucleic acid analogs

0

...

Patent Primary Examiner

0

Patent abstract

The present embodiments provide methods, compounds, and compositions useful for inhibiting PMP22 expression and for treating, preventing, or ameliorating a disease associated with PMP22.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11959080 Methods and compositions for inhibiting PMP22 expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.